Literature DB >> 16912569

Influence of phytoestrogens on the proliferation and expression of adhesion receptors in human mammary epithelial cells in vitro.

Barbara Nebe1, Annelie Peters, Kathrin Duske, Dagmar-Ulrike Richter, Volker Briese.   

Abstract

Tumor metastasis is associated with integrin-mediated adhesion and hyaluronan receptor expression. Accumulating evidence suggests that phytoestrogens, which are naturally occurring, plant-derived phytochemicals, could inhibit tumorigenesis during the development of breast cancer. Less is known, however, about the regulation of adhesion receptors by phytoestrogens and, particularly, their potency to influence proliferation of primary human breast cells in comparison with the steroid hormone 17beta-estradiol. Throughout the proliferation experiments, we used primary human mammary epithelial cells from normal tissue that was derived from plastic surgery. For receptor expression (beta1, alpha2, alpha3, CD44), we used the cell line MCF-7. Both investigations were carried out by flow cytometry. The phenotype of primary human mammary epithelial cells was microscopically characterized by analyzing the distribution of ZO-1, cytokeratin and the estrogen receptors alpha and beta. The integrins and the hyaluronan receptor were significantly up-regulated with 17beta-estradiol in human MCF-7 cells. In contrast, genistein and daidzein did not affect the expression at a concentration of 100 micromol/l. In all proliferation experiments with a significant stimulation of the primary human mammary epithelial cell growth due to 17beta-estradiol, in general, genistein and daidzein did not influence S-phase and G2/M-phase cells. Additionally, the stimulative effect of 17beta-estradiol could be inhibited. As the phytoestrogens do not up-regulate adhesion receptors in human breast cells and, regarding proliferation, are able to abolish the stimulatory effect of 17beta-estradiol, we suggest that phytoestrogens could have beneficial effects for the prevention or inhibition of carcinogenesis in hormone-dependent malignancies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912569     DOI: 10.1097/00008469-200610000-00005

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  8 in total

Review 1.  Minireview: Steroid/nuclear receptor-regulated dynamics of occluding and anchoring junctions.

Authors:  Gary L Firestone; Bhumika J Kapadia
Journal:  Mol Endocrinol       Date:  2014-09-09

2.  Implications of single nucleotide polymorphisms in CD44 exon 2 for risk of breast cancer.

Authors:  Juhua Zhou; Prakash S Nagarkatti; Yin Zhong; Jiajia Zhang; Mitzi Nagarkatti
Journal:  Eur J Cancer Prev       Date:  2011-09       Impact factor: 2.497

3.  Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein.

Authors:  Ana M Sotoca; Maarten D Sollewijn Gelpke; Sjef Boeren; Anders Ström; Jan-Åke Gustafsson; Albertinka J Murk; Ivonne M C M Rietjens; Jacques Vervoort
Journal:  Mol Cell Proteomics       Date:  2010-09-30       Impact factor: 5.911

4.  Regulation of zinc transporters by dietary flaxseed lignan in human breast cancer xenografts.

Authors:  Lian-ying Zhang; Xiao-lei Wang; Dao-xu Sun; Xian-xi Liu; Xiao-yan Hu; Feng Kong
Journal:  Mol Biol Rep       Date:  2007-09-05       Impact factor: 2.316

5.  A preliminary study of the effectiveness of chinese therapeutic food on regulating female reproductive hormones.

Authors:  Lulu Fu; Hong Xu
Journal:  Integr Med Insights       Date:  2011-03-24

6.  Simultaneous inhibition of cell-cycle, proliferation, survival, metastatic pathways and induction of apoptosis in breast cancer cells by a phytochemical super-cocktail: genes that underpin its mode of action.

Authors:  Allal Ouhtit; Rajiv Lochan Gaur; Mohamed Abdraboh; Shubha K Ireland; Prakash N Rao; Shailaja G Raj; Hamad Al-Riyami; Somya Shanmuganathan; Ishita Gupta; Subramanyam N Murthy; Andrew Hollenbach; Madhwa Hg Raj
Journal:  J Cancer       Date:  2013-11-14       Impact factor: 4.207

7.  Metabolic profiling reveals sphingosine-1-phosphate kinase 2 and lyase as key targets of (phyto-) estrogen action in the breast cancer cell line MCF-7 and not in MCF-12A.

Authors:  Nadja Engel; Jan Lisec; Birgit Piechulla; Barbara Nebe
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

8.  Pro-apoptotic and anti-adhesive effects of four African plant extracts on the breast cancer cell line MCF-7.

Authors:  Nadja Engel; Abiodun Falodun; Juliane Kühn; Udo Kragl; Peter Langer; Barbara Nebe
Journal:  BMC Complement Altern Med       Date:  2014-09-09       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.